VolitionRx (VNRX) stock jumped 70% in pre-market after achieving 99% pure tumor DNA isolation and detecting 49/49 cancers in a blind study. The post VolitionRx (VNRX) Stock Soars 70% on Revolutionary Cancer DNA Discovery appeared first on Blockonomi.